Certolizumab pegol efficacy is greater with more recent-onset Crohn's Disease: PRECiSE 2 results

Sandborn, W. and Colombel, J. and Panes, P. and Schoelmerich, J. and McColm, J. and Schreiber, S. (2007) Certolizumab pegol efficacy is greater with more recent-onset Crohn's Disease: PRECiSE 2 results. INFLAMMATORY BOWEL DISEASES, 13 (5Suppl). p. 672. ISSN 1078-0998

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin I
Depositing User: Petra Gürster
Date Deposited: 29 Oct 2020 09:20
Last Modified: 29 Oct 2020 09:20
URI: https://pred.uni-regensburg.de/id/eprint/32819

Actions (login required)

View Item View Item
pred is powered by EPrints 3.4 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.